Name: Avanos Medical, Inc. (AVNS) Financial Statements
Creator: FinSpry

Avanos Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Avanos Medical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	687.80	673.30	684.10	587.00	714.80	697.60	652.30
Cost of Revenue	306.50	293.60	289.90	287.80	343.90	295.40	261.40
Gross Profit	381.30	379.70	394.20	299.20	370.90	402.20	390.90
Operating Expenses
Research & Development	12.40	27.20	29.20	30.60	34.90	37.70	41.80
Selling, General & Administrative	321.10	335.00	326.50	285.30	327.20	399.10	340.40
Operating Expenses	336.50	375.50	358.70	338.20	366.50	457.90	390.40
Operating Income	44.80	4.20	35.50	-39.00	4.40	-55.70	0.50
Other Income/Expense
Interest Income	5.10	2.90	1.20	0.20	1.20	0.00	7.80
Interest Expense	-12.20	15.00	-10.00	3.30	-15.60	0.00	26.40
Other Income/Expense	-436.70	0.00	7.80	1.80	9.60	-734.10	0.00
Income
Income Before Tax	-403.30	-7.90	26.70	-42.10	-62.90	-64.00	-18.10
Income Tax Expense	-17.00	2.00	5.20	-11.20	-33.90	-18.10	-9.60
Net Income	-392.10	-61.80	50.50	6.30	-29.00	-45.90	57.50
Net Income - Continuous Operations	-386.30	-9.90	21.50	-30.90	0.00	0.00	0.00
Net Income - Discontinued Operations	-5.80	-51.90	29.00	37.20	0.00	0.00	0.00
EBITDA	90.30	53.20	76.70	-0.50	47.30	-12.10	41.80
EBIT	44.80	7.10	35.50	-38.80	4.40	-49.00	8.30
Depreciation & Amortization	45.50	46.10	41.20	38.30	42.90	16.90	0.00
Earnings Per Share
Basic EPS	-9.00	-1.00	1.00	-	-1.00	-1.00	1.00
Diluted EPS	-9.00	-1.00	1.00	-	-1.00	-1.00	1.00
Basic Shares Outstanding	46.00	46.60	46.90	48.10	47.80	47.60	47.20
Diluted Shares Outstanding	46.00	46.60	47.30	48.60	47.80	47.60	47.20